Print Page  |  Close Window


Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.

MEDP (Common Stock)
Change (%)  -0.8 (2.12%)
Volume 118,480
Date as of  04/19/18 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: MEDP.O.  Currently trading at $36.90 with a 52 week high of $39.64 and a 52 week low of $21.76.

Upcoming Events

Friday, May 18, 2018 9:00 a.m. ETMedpace Holdings, Inc. Annual Shareholder Meeting

View all events

Primary IR Contact

Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
Phone: +1.513.579.9911